tiprankstipranks
Advertisement
Advertisement

INAB Stock Latest News

IN8bio therapy doubles progression free survival in brain cancer trial
The FlyIN8bio therapy doubles progression free survival in brain cancer trial
25d ago
INAB
IN8bio announces updated INB-200, INB-400 study data
PremiumThe Fly
IN8bio announces updated INB-200, INB-400 study data
2M ago
INAB
IN8bio launches new JonesTrading at-the-market program
PremiumCompany Announcements
IN8bio launches new JonesTrading at-the-market program
2M ago
8K
INAB
IN8bio Reports Q1 2026 Results and Shareholder Votes
PremiumCompany Announcements
IN8bio Reports Q1 2026 Results and Shareholder Votes
3M ago
8K
INAB
Is INAB a Buy, Before Earnings?
PremiumPre-Earnings
Is INAB a Buy, Before Earnings?
5M ago
INAB
IN8bio Announces Board Resignation and Interim Chair Appointment
PremiumCompany AnnouncementsIN8bio Announces Board Resignation and Interim Chair Appointment
5M ago
8K
INAB
IN8bio Elevates COO Kate Rochlin to President
Premium
Company Announcements
IN8bio Elevates COO Kate Rochlin to President
6M ago
8K
INAB
IN8bio appoints Kate Rochlin as president
Premium
The Fly
IN8bio appoints Kate Rochlin as president
6M ago
INAB
IN8bio files to sell 14.38M shares of common stock for holders
PremiumThe Fly
IN8bio files to sell 14.38M shares of common stock for holders
6M ago
INAB
IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating
PremiumRatings
IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating
7M ago
INAB
IN8bio presents Phase I/II data from INB-200 trials
PremiumThe Fly
IN8bio presents Phase I/II data from INB-200 trials
7M ago
INAB
IN8bio Announces Structured $40 Million Private Placement Financing
PremiumCompany Announcements
IN8bio Announces Structured $40 Million Private Placement Financing
8M ago
8K
INAB
IN8bio prices 5.13M shares at $1.38 in private placement
PremiumThe FlyIN8bio prices 5.13M shares at $1.38 in private placement
8M ago
INAB
IN8bio Presents Promising Clinical Trial Results
Premium
Company Announcements
IN8bio Presents Promising Clinical Trial Results
8M ago
8K
INAB
IN8bio files $200M mixed securities shelf
Premium
The Fly
IN8bio files $200M mixed securities shelf
9M ago
INAB
IN8Bio Reports Improved Financials Amid Ongoing Challenges
PremiumCompany Announcements
IN8Bio Reports Improved Financials Amid Ongoing Challenges
9M ago
INAB
IN8bio expands INB-100 Phase 1 trial with new clinical site
PremiumThe Fly
IN8bio expands INB-100 Phase 1 trial with new clinical site
9M ago
INAB
IN8bio Unveils Promising Preclinical Data for INB-619
PremiumCompany Announcements
IN8bio Unveils Promising Preclinical Data for INB-619
9M ago
8K
INAB
IN8bio presents new preclinical data from INB-619
PremiumThe Fly
IN8bio presents new preclinical data from INB-619
9M ago
INAB
IN8bio price target adjusted to $4 from $60 at Mizuho
PremiumThe FlyIN8bio price target adjusted to $4 from $60 at Mizuho
10M ago
INAB
Positive Outlook on IN8bio: Buy Rating Backed by Promising Pipeline Developments and Strategic Financial Adjustments
Premium
Ratings
Positive Outlook on IN8bio: Buy Rating Backed by Promising Pipeline Developments and Strategic Financial Adjustments
12M ago
INAB
In8bio, Inc. Reports Improved Financial Performance
Premium
Company Announcements
In8bio, Inc. Reports Improved Financial Performance
12M ago
INAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >